When will the US admit that our tax system, our publicly funded research and our patent system are not serving the public interest? Using Gilead Sciences as an example, take a look a how the American public has paid for Gilead’s Sovaldi – not once, but twice so far – and we’re still paying. Gilead is not the only pharmaceutical company using techniques like price gouging and tax dodging. Find out more here. (Source: Bernie Sanders, The Huffington Post, 7/13/16)
You are here: / / How Many Times are We Paying for a Prescription?